THC: Clinical Trials

1 trial for THC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Suspended 1

Follow THC: new trials by email Literature Review of THC trials Research Report on THC

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment
THC ~2.5%, THC ~5%, THC ~10% - Migraine, Cannabis
Phase 2SuspendedUniversity of California, San Diego202023-02-152026-03-16

Narrower conditions

Marijuana Abuse (1)  ·  Migraine Disorders (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Headache Disorders (1)  ·  Headache Disorders, Primary (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Substance-Related Disorders (1)

Interventions

Dronabinol (1)  ·  THC 5 (1)  ·  nabiximols (1)  ·  salicylhydroxamic acid (1)

Sponsors

University of California, San Diego (1)

Countries

United States (1)

Top investigators

Nathaniel M Schuster, MD (1)